Hypertension drug may benefit diabetics, researchers say

09/26/2008 | Yahoo!

Candesartan, a blood-pressure drug, decreased the incidence of retinopathy in patients with Type 1 diabetes by 18% and lowered progression of the eye disorder by 35%, U.K. researchers reported. The findings add to evidence of the potential of the drug -- sold by AstraZeneca and Takeda Pharmaceutical as Atacand -- to reduce or prevent diabetic retinopathy.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA